Guillaume C. Onyeaghala

Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk

Anna E. Prizment, Christopher Staley, Guillaume C. Onyeaghala et al. · Alimentary Pharmacology & Therapeutics · 2020 · 65 citations · Full text

Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention guidelines and colorectal cancer incidence among African Americans and whites: The Atherosclerosis Risk in Communities study

Guillaume C. Onyeaghala, Anna K. Lintelmann, Corrine E. Joshu et al. · Cancer · 2019 · 28 citations · Full text

Prospective Association of Serum and Dietary Magnesium with Colorectal Cancer Incidence

Elizabeth J. Polter, Guillaume C. Onyeaghala, Pamela L. Lutsey et al. · Cancer Epidemiology Biomarkers & Prevention · 2019 · 27 citations · Full text

Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements

Mohammad H. Khan, Guillaume C. Onyeaghala, Armin Rashidi et al. · Gut Microbes · 2022 · 14 citations · Full text

Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma

Ajay Prakash, Nathan Rubin, Christopher Staley et al. · Scientific Reports · 2024 · 13 citations · Full text